# Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis

> **NCT07171112** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 45 (estimated)

## Conditions studied

- Pancreatitis, Chronic
- Pancreatitis, Acute
- Recurrent Acute Pancreatitis
- Smoking (Tobacco) Addiction

## Interventions

- **DRUG:** Standard Varenicline Dosing (1 mg BID)
- **DRUG:** Bupropion 150 mg twice daily
- **DRUG:** Increased Varenicline Dosing (1mg TID)

## Key facts

- **NCT ID:** NCT07171112
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-06
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07171112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07171112, "Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07171112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*